A report, by Research & Markets, about 3D printing (also called “additive manufacturing”), discusses how the technology–often used in tissue engineering–could be applied to drug production. 3D printing is a family of technologies that implement layer-by-layer processes in order to fabricate physical models, based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees of complexity with great reproducibility, in a fast and cost-effective fashion.
3D printing has been used extensively in tissue and organ engineering, diagnostics, disease modeling, manufacturing of biomedical devices and the design and development of novel dosage forms. It is utilized in the pharmaceutical industries as a process innovation technology to construct digitally controlled and personalized products by converting a concept into a prototype additive manufacturing using 3D computer-aided design (CAD) or a Magnetic Resonance Image (MRI).
https://www.researchandmarkets.com/r/bxcdfd